AAAAAA
Results: 1-25/43
Authors:
CULLIVAN R
CROWN J
WALSH N
Citation: R. Cullivan et al., THE USE OF PSYCHOTROPIC MEDICATION IN PATIENTS REFERRED TO A PSYCHO-ONCOLOGY SERVICE, Psycho-oncology (Chichester), 7(4), 1998, pp. 301-306
Authors:
DILEO A
CROWN J
NOGARET LM
DUFFY K
BARTHOLOMEUS S
DOLCI S
ROWAN S
OHIGGINS N
RIVA A
PICCART MJ
Citation: A. Dileo et al., DOXORUBICIN (A) FOLLOWED BY DOCETAXEL (T) VERSUS DOXORUBICIN PLUS DOCETAXEL (AT) IN THE ADJUVANT TREATMENT OF BREAST-CANCER (BC), European journal of cancer, 34, 1998, pp. 166-166
Authors:
DILEO A
CROWN J
NOGARET JM
DUFFY K
BARTHOLOMEUS S
ROWAN S
DOLCI S
OHIGGINS N
RIVA A
PICCART MJ
Citation: A. Dileo et al., FEASIBILITY OF DOCETAXEL (D)-CONTAINING REGIMENS IN THE ADJUVANT TREATMENT (AT) OF BREAST-CANCER (BC), European journal of cancer, 34, 1998, pp. 85-85
Authors:
BOURKE T
CARR A
FENNELLY D
MCDERMOTT E
CROWN J
Citation: T. Bourke et al., IMPROVED DOCTOR PATIENT COMMUNICATION INDEXES IN ONCOLOGY - RESULTS OF A PROSPECTIVE, CONTROLLED EVALUATION AND INTERVENTION BASED ON THE E4 MODEL/, Annals of oncology, 9, 1998, pp. 677-677
Authors:
ROSTI G
FERRANTE P
LADENSTEIN R
KOSCELNIAK E
LEYVRAZ S
LEDERMANN J
ROCHE H
BIRON P
NIEDERWIESER D
CROWN J
CHAUVIN F
Citation: G. Rosti et al., THE EBMT SOLID TUMORS WORKING PARTY AND REGISTRY ACTIVITY - 1997 REPORT, Bone marrow transplantation, 21, 1998, pp. 812-812
Authors:
BERTIN ML
CROWN J
GORDON SM
Citation: Ml. Bertin et al., DETERMINANTS OF SURGICAL SITE INFECTION AFTER BREAST SURGERY, American journal of infection control, 26(1), 1998, pp. 61-65
Authors:
DONNELLAN P
ARMSTRONG J
ROWAN S
FENNELLY D
LYNCH V
MCDONNELL T
MCNICHOLAS W
CROWN J
Citation: P. Donnellan et al., NEW CHEMOTHERAPY COMBINATIONS WITH DOCETAXEL IN THE TREATMENT OF PATIENTS WITH NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(3), 1998, pp. 20-23
Authors:
CROWN J
CLARKE M
Citation: J. Crown et M. Clarke, BRITAIN FIRST MINISTER OF PUBLIC-HEALTH - NATIONAL PUBLIC-HEALTH RESEARCH-AND-DEVELOPMENT PROGRAM IS NEEDED, BMJ. British medical journal, 315(7099), 1997, pp. 54-55
Authors:
DILEO A
CROWN J
NOGARET JM
DUFFY K
BARTHOLOMEUS S
ROWAN S
OHIGGINS N
RIVA A
PICCART MJ
Citation: A. Dileo et al., SEQUENTIAL ADRIAMYCIN (A), DOCETAXEL (D) AND CMF IN THE ADJUVANT TREATMENT (AT) OF BREAST-CANCER (BC), European journal of cancer, 33, 1997, pp. 359-359
Authors:
CROWN J
Citation: J. Crown, OPTIMIZING TREATMENT OUTCOMES - A REVIEW OF CURRENT MANAGEMENT STRATEGIES IN FIRST-LINE CHEMOTHERAPY OF METASTATIC BREAST-CANCER, European journal of cancer, 33, 1997, pp. 15-19
Authors:
MAGUIRE TM
SHERING SG
MCDERMOTT EW
OHIGGINS N
FENNELLY JJ
CROWN J
DUFFY MJ
Citation: Tm. Maguire et al., ASSAY OF E-CADHERIN BY ELISA IN HUMAN BREAST CANCERS, European journal of cancer, 33(3), 1997, pp. 404-408
Authors:
CROOCKEWIT AJ
BRONCHUD MH
AAPRO MS
BARGETZI MJ
CROWN J
GRATWOHL A
LANGE W
LUDWIG H
MARTINELLI G
MERTELSMANN R
NUESSLER V
WILLEMZE R
DEWITTE TJM
ZITTOUN R
ZWIERZINA H
Citation: Aj. Croockewit et al., A EUROPEAN PERSPECTIVE ON HEMATOPOIETIC GROWTH-FACTORS IN HEMATOONCOLOGY - REPORT OF AN EXPERT MEETING OF THE EORTC, European journal of cancer, 33(11), 1997, pp. 1732-1746
Authors:
CROWN J
Citation: J. Crown, THE FACULTYS 25TH ANNIVERSARY, Journal of public health medicine, 19(3), 1997, pp. 249-250
Authors:
CROWN J
Citation: J. Crown, HIGH-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER - THE END OF THE BEGINNING, British Journal of Cancer, 75(4), 1997, pp. 467-469
Authors:
CROWN J
Citation: J. Crown, HIGH-DOSE CHEMOTHERAPY IN RESISTANT BREAST-CANCER, Breast, 5(4), 1996, pp. 298-303
Authors:
OREILLY E
CROWN J
Citation: E. Oreilly et J. Crown, 2ND CANCERS COMPLICATING HODGKINS-DISEASE, Annals of oncology, 7(4), 1996, pp. 405-408
Authors:
HUDIS C
SEIDMAN A
RAPTIS G
FENNELLY D
GILEWSKI T
BASELGA J
THEODOULOU M
SKLARIN N
MOYNAHAN M
SURBONE A
CURRIE V
LEBWOHL D
UHLENHOPP M
CROWN J
NORTON L
Citation: C. Hudis et al., SEQUENTIAL ADJUVANT THERAPY - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER EXPERIENCE, Seminars in oncology, 23(1), 1996, pp. 58-64
Authors:
CROWN J
Citation: J. Crown, CURRENT STATUS OF HIGH-DOSE CHEMOTHERAPY IN BREAST-CANCER, British Journal of Cancer, 74, 1996, pp. 8-8
Authors:
CROWN J
Citation: J. Crown, CURRENT STATUS OF HIGH-DOSE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, British Journal of Cancer, 73(8), 1996, pp. 1015-1015
Authors:
VAHDAT L
RAPTIS G
FENNELLY D
HAMILTON N
REICH L
TIERSTEN A
HARRISON M
HUDIS C
MOORE M
YAO TJ
NORTON L
CROWN J
Citation: L. Vahdat et al., RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER, Clinical cancer research, 1(11), 1995, pp. 1267-1273
Authors:
CROWN J
RAPTIS G
HAMILTON N
FENNELLY D
VAHDAT L
NORTON L
Citation: J. Crown et al., HIGH-DOSE CHEMOTHERAPY OF BREAST-CANCER - CURRENT STATUS AND DEVELOPMENTAL STRATEGIES, European journal of cancer, 31A(5), 1995, pp. 809-811
Authors:
DUFFY MJ
DUGGAN C
MULCAHY H
MCDERMOTT EW
FENELLY JJ
CROWN J
OHIGGINS NJ
Citation: Mj. Duffy et al., UROKINASE PLASMINOGEN-ACTIVATOR, A POTENTIAL PROGNOSTIC MARKER FOR NODE-NEGATIVE BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 662-662
Authors:
CROWN J
HAMILTON N
RAPTIS G
KRITZ A
VAHDAT L
NORTON L
Citation: J. Crown et al., CARBOPLATIN AND ETOPOSIDE IN METASTATIC BREAST-CANCER, Annals of oncology, 6(4), 1995, pp. 403-403
Authors:
CROWN J
NORTON L
Citation: J. Crown et L. Norton, POTENTIAL STRATEGIES FOR IMPROVING THE RESULTS OF HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 6, 1995, pp. 21-26
Authors:
CROWN J
Citation: J. Crown, HIGH-DOSE CHEMOTHERAPY OF SOLID TUMORS, Annals of oncology, 6, 1995, pp. 11-15